fibrinogen has been researched along with Lymphoma, B-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akassoglou, K; Chan, JP; Gao, HX; Mendiola, AS; Merlini, M; Rubenstein, JL; Ryu, JK | 1 |
| Habara, T; Kiguchi, T; Miyamoto, I; Nakano, M; Niiya, K; Sadatani, K; Sasaki, K; Sonobe, H | 1 |
| Binkovski, N; Cherny, I; Inbal, A; Lederfein, D; Peretz, A; Rabizadeh, E; Sherman, S; Wolach, O | 1 |
3 other study(ies) available for fibrinogen and Lymphoma, B-Cell
| Article | Year |
|---|---|
Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma.
Topics: Animals; Biological Transport; Cell Adhesion; Central Nervous System Neoplasms; Disease Models, Animal; Fibrinogen; Humans; Inflammation; Lymphocytes; Lymphoma, B-Cell; Male; Mice; Mice, Nude | 2021 |
Prolonged Activated Partial Thromboplastin Time and False-Positive Results for Fibrinogen and Fibrin Degradation Products in a B-Cell Lymphoma Patient.
Topics: Aged, 80 and over; False Positive Reactions; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin M; Lymphoma, B-Cell; Male; Partial Thromboplastin Time; Prognosis | 2018 |
Increased activity of cell membrane-associated prothrombinase, fibrinogen-like protein 2, in peripheral blood mononuclear cells of B-cell lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cell Membrane; Female; Fibrinogen; Humans; Leukocytes, Mononuclear; Lymphoma, B-Cell; Male; Middle Aged; Thromboplastin | 2014 |